Levocetirizin Ab

Levocetirizine, the active ingredient in Levocetirizin Ab, is a second‑generation H1 antihistamine presented as a tablet for oral use. It is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria in adults and children. GNH USA supplies Levocetirizin Ab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine is a selective peripheral H1‑receptor antagonist used to manage allergic conditions. - Allergic rhinitis: reduces nasal congestion, sneezing, itching and watery discharge. - Seasonal allergic rhinitis: alleviates symptoms triggered by pollen or outdoor allergens. - Chronic idiopathic urticaria: diminishes the frequency and severity of hives and associated itching.

Levocetirizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness: mild to moderate sedation, especially at the start of therapy. - Headache: transient, often resolves without intervention. - Dry mouth: reduced salivation causing mild discomfort. - Fatigue: feeling of tiredness that may improve with continued use. - Nausea: occasional stomach upset.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue requiring urgent care. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylaxis: rare systemic allergic response with respiratory compromise. - Thrombocytopenia: low platelet count, may present with easy bruising. - Hepatic injury: abnormal liver function tests, monitor if symptoms arise.

Before initiating Levocetirizin Ab, consider the following safety measures. - Renal impairment: adjust dose or monitor closely in patients with reduced kidney function. - Hypersensitivity: discontinue if signs of allergic reaction to levocetirizine occur. - Concomitant CNS depressants: use caution as combined sedation may increase. - Elderly patients: start with the lowest effective dose due to increased sensitivity. - Alcohol consumption: limit intake to reduce additive drowsiness. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Levocetirizin Ab may interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Other H1 antihistamines: additive sedation and reduced efficacy. - Alcohol or CNS depressants: heightened drowsiness and impaired coordination.

Moderate Interactions (Monitor Closely): - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may increase plasma concentrations. - Theophylline: potential for altered theophylline levels. - Anticholinergic agents: may exacerbate dry mouth. - Diuretics: monitor for changes in electrolyte balance.